We're a US-based head & neck pathology society that connects oral and ENT pathologists, fellows, residents, and students from around the world! @HeadNeckPathol
COLCA2 fusions in sinonasal adenoid cystic carcinoma. Kind of makes you wonder about the keratin positive sinonasal โsarcomasโโฆ ๐ค https://t.co/yYQd7kkZSz
Virchows Archiv reports a case of intraductal carcinoma (IDC) in the parotid gland with NCOA4::RET fusion, showing extensive infiltrative growth despite low-grade cribriform histomorphology. This challenges existing perceptions of IDC behavior.
https://t.co/0Vmpg9bOSO
Epithelioid Sarcoma of the Oral Cavity: A Multi-institutional Clinicopathologic & Immunophenotypic Characterization of Five Cases & Comprehensive Literature Review
Argyris et al
https://t.co/xN4bhG1RkB
#HeadNeckPathol#HNPJ#HeadandNeckPath#Pathology#ENTPath#PathologyTweet
Genomic & Epigenetic Comparative Study of Low-grade Biphenotypic Sinonasal Sarcoma w/ Metachronous &Synchronous High-grade Rhabdomyosarcomatous Transformation
Sibira, Chen, et al
https://t.co/jZb8NAvKzr
#HeadNeckPathol#HNPJ#HeadandNeckPath#Pathology#ENTPath#PathologyTweet
DICER1 mutations in Bethesda category II, III, and IV thyroid nodules: A mutually exclusive relationship with BRAFV600E mutation
https://t.co/l5wiC5rVd4
#CytoPath
Virchows Archiv reports on cribriform morular thyroid carcinoma (CMTC), a rare tumor often linked to familial adenomatous polyposis. This study details a sporadic case in a 44-year-old female with significant tumor features and mutations.
https://t.co/sCZSAqhchv
Virchows Archiv reviews significant updates in salivary gland pathology from 2022-2025, highlighting new tumor entities like palisading adenocarcinoma and microcribriform adenocarcinoma not included in the WHO 2024 classification.
https://t.co/skT3jw2Mhq
New #OpenAccess review by N. Paul Ohori MD of @UPMCPathology et al details the fascinating history of PTC nuclei & summarizes the major events representing the paradigm shifts, classification system changes, and controversies: https://t.co/wtOPRCUr9M #CytoPath#ENTPath
First #USCAP invited talk completed!Thanks again for the kind invitation by @NASHNPath. It was truly an honor to be included among these great speakers. Now I can finally relax and enjoy the rest of the meeting lol
#USCAP2026#thyroid#ENTPath